Affiliation:
1. Russian University of Sports “GTSOLIFK”
Abstract
In this review of the subject field, the brain natriuretic peptide and its predecessor, the N-terminal pro-brain natriuretic peptide, are considered as a marker for evaluating the effectiveness of rehabilitation programs, including physical activity, in diseases such as arterial hypertension, chronic heart failure, coronary heart disease and other diseases. In addition, the reaction of this peptide to physical activity in healthy people is considered.
Reference18 articles.
1. Simão A. F., Précoma D. B., de Andrade J. P., Filho H. C., Saraiva J. F.K., Oliveira G. M.M. I diretriz brasileira de prevenção cardiovascular. Arq. Bras. Cardiol. 2014; 102: 420–431. DOI: 10.5935/abc.2013S 012
2. Cao Z., Jia Y., Zhu B. BNP and NT-proBNP as Diagnostic Biomarkers for Cardiac Dysfunction in Both Clinical and Forensic Medicine. Int J. Mol. Sci. 2019 Apr 12
3. 20 (8): 1820. DOI: 10.3390/ijms20081820
4. Schmitt W., Rühs H., Burghaus R., Diedrich C., Duwal S., Eissing T., Garmann D., Meyer M., Ploeger B., Lippert J. NT-proBNP Qualifies as a Surrogate for Clinical End Points in Heart Failure. Clin. Pharmacol. Ther. 2021 Aug; 110 (2): 498–507. DOI: 10.1002/cpt.2222
5. Fan J., Ma J., Xia N., Sun L., Li B., Liu H. Clinical Value of Combined Detection of CK-MB, MYO, cTnI and Plasma NT-proBNP in Diagnosis of Acute Myocardial Infarction. Clin. Lab. 2017 Mar 1; 63 (3): 427–433. DOI: 10.7754/Clin.Lab.2016.160533